- Rank in Search Criteria: 4871
World Rank (Jan-05-2024): 16,447
Market Cap (Jan-05-2024): 0.27 Billion USD
World Rank (Jul-30-2023): 17663
Market Cap (Jul-30-2023): 0.22 Billion USD
World Rank (Jan-2022): 20,454
Market Cap (Jan-2022): 0.15 Billion USDHeadquarters Country: USA Company Profile: Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
- Rank in Search Criteria: 4872
World Rank (Jan-05-2024): 16,449
Market Cap (Jan-05-2024): 0.27 Billion USD
World Rank (Jul-30-2023): 15992
Market Cap (Jul-30-2023): 0.29 Billion USD
World Rank (Jan-2022): 14,133
Market Cap (Jan-2022): 0.45 Billion USDHeadquarters Country: USA Annual Revenue in USD: 35 Million USD
Annual Net Income in USD: 33 Million USD
Annual Results for Period ending: Nov-2019 ending year
- Rank in Search Criteria: 4873
World Rank (Jan-05-2024): 16,450
World Rank (Jul-30-2023): 16450
Market Cap (Jul-30-2023): 0.27 Billion USD
World Rank (Jan-2022): 15,271
Headquarters Country: USA
- Rank in Search Criteria: 4874
World Rank (Jan-05-2024): 16,451
Market Cap (Jan-05-2024): 0.27 Billion USD
World Rank (Jul-30-2023): 16139
Market Cap (Jul-30-2023): 0.29 Billion USD
World Rank (Jan-2022): 16,312
Market Cap (Jan-2022): 0.32 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4875
World Rank (Jan-05-2024): 16,454
Market Cap (Jan-05-2024): 0.27 Billion USD
World Rank (Jul-30-2023): 18094
Market Cap (Jul-30-2023): 0.20 Billion USD
World Rank (Jan-2022): 18,424
Market Cap (Jan-2022): 0.22 Billion USDHeadquarters Country: USA Annual Revenue in USD: 274 Million USD
Annual Net Income in USD: 26 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 4876
World Rank (Jan-05-2024): 16,457
World Rank (Jul-30-2023): 16457
World Rank (Jan-2022): 16,457
Headquarters Country: USA
- Rank in Search Criteria: 4877
World Rank (Jan-05-2024): 16,460
Market Cap (Jan-05-2024): 0.26 Billion USD
World Rank (Jul-30-2023): 15562
Market Cap (Jul-30-2023): 0.32 Billion USD
World Rank (Jan-2022): 10,150
Market Cap (Jan-2022): 0.88 Billion USDAnnual Revenue in USD: 234 Million USD
Annual Net Income in USD: 2 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 4878
World Rank (Jan-05-2024): 16,461
Market Cap (Jan-05-2024): 0.26 Billion USD
World Rank (Jul-30-2023): 16391
Market Cap (Jul-30-2023): 0.27 Billion USD
World Rank (Jan-2022): 16,860
Market Cap (Jan-2022): 0.29 Billion USD
- Rank in Search Criteria: 4879
World Rank (Jan-05-2024): 16,469
World Rank (Jul-30-2023): 16469
Market Cap (Jul-30-2023): 0.27 Billion USD
World Rank (Jan-2022): 13,670
Market Cap (Jan-2022): 0.48 Billion USDHeadquarters Country: USA Annual Revenue in USD: 119 Million USD
Annual Net Income in USD: -103 Million USD
Annual Results for Period ending: Dec-2021 ending year
- Rank in Search Criteria: 4880
World Rank (Jan-05-2024): 16,474
Market Cap (Jan-05-2024): 0.26 Billion USD
World Rank (Jul-30-2023): 13809
Market Cap (Jul-30-2023): 0.42 Billion USD
World Rank (Jan-2022): 15,576
Market Cap (Jan-2022): 0.36 Billion USDHeadquarters Country: USA Annual Revenue in USD: 205 Million USD
Annual Net Income in USD: 47 Million USD
Annual Results for Period ending: Dec-2020 ending year